Literature DB >> 8950152

Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro.

A Jordan1, P Wust, R Scholz, B Tesche, H Fähling, T Mitrovics, T Vogl, J Cervós-Navarro, R Felix.   

Abstract

Suspensions of coated superparamagnetic particles (magnetic fluids, MF) in AC magnetic fields have a pronounced specific absorption rate (SAR) per mass compared to multidomain particles. The aim of the present study was to investigate cellular uptake and the biological effects of AC magnetic field excited bio-compatible magnetic fluids on human carcinoma cells in vitro. One of the fluids tested was a dextran magnetite, which has a very low cyto-toxicity with survival fractions (SF) between 0.8 and 0.9 at concentrations of up to 5 mg ferrite per ml. Human carcinoma cells intracellularly accumulate up to 1 pg ferrite/cell which has been demonstrated by electron microscopy (TEM), X-ray spectroscopy and measurements of intracellular iron. It has been shown that the ferrite core is not altered intracellularly, but many of the dextran shells are degraded which yields particle chains and other aggregates observed in TEM. Semi-solid pellets of the tumour cells were treated with AC magnetic fields (520 kHz, 4-12.5 kA/m) or waterbath hyperthermia at 43 and 45 degrees C, in presence of extracellular and/or intracellular magnetic fluid particles. Although MF heating is produced from individual particles, the survival fractions of MF heated and water bath heated cells are equal. In fact, the extracellular MF particle distribution is homogeneous enough to obtain similar inactivation. In contrast to earlier reports intracellular dextran magnetite particles in AC magnetic fields did not induce cell inactivation. Since the amount of intracellular ferrite should be indeed large enough for cell inactivation, the loss of dextran shells is most probably the main cause of limited effectiveness of the intracellular magnetite particles. The present work has demonstrated that: (1) MFH is able to inactivate tumour cells in vitro to at least the same extent as water bath hyperthermia; and (2) that there is a sensitizer effect of ferrofluids at 43 degrees C probably caused by free ferric ions which induce oxidative stress; and (3) that there is no cytotoxic effect of intracellular dextran magnetite particles 30-180 min excited with AC magnetic fields used in this study. For the new method the term 'magnetic fluid hyperthermia (MFH)' is proposed.

Entities:  

Mesh:

Year:  1996        PMID: 8950152     DOI: 10.3109/02656739609027678

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  35 in total

1.  Effect of the concentration of magnetic grains on the linear-optical-absorption coefficient of ferrofluid-doped lyotropic mesophases: deviation from the Beer-Lambert law.

Authors:  F L S Cuppo; S L Gómez; A M Figueiredo Neto
Journal:  Eur Phys J E Soft Matter       Date:  2004-04       Impact factor: 1.890

2.  In vitro tagging of embryos with nanoparticles.

Authors:  Tricia L Fynewever; Evelyn S Agcaoili; John D Jacobson; William C Patton; Philip J Chan
Journal:  J Assist Reprod Genet       Date:  2006-12-29       Impact factor: 3.412

3.  Differential interaction of magnetic nanoparticles with tumor cells and peripheral blood cells.

Authors:  J H Clement; M Schwalbe; N Buske; K Wagner; M Schnabelrauch; P Görnert; K O Kliche; K Pachmann; W Weitschies; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-24       Impact factor: 4.553

Review 4.  Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.

Authors:  Frederik Soetaert; Preethi Korangath; David Serantes; Steven Fiering; Robert Ivkov
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

5.  Iron Oxide Hyperthermia And Radiation Cancer Treatment.

Authors:  Sm Cassim; Aj Giustini; Aa Petryk; Ra Strawbridge; Pj Hoopes
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-23

6.  Assessment of intratumor non-antibody directed iron oxide nanoparticle hyperthermia cancer therapy and antibody directed IONP uptake in murine and human cells.

Authors:  Pj Hoopes; Ja Tate; Ja Ogden; Rr Strawbridge; Sn Fiering; Aa Petryk; Sm Cassim; Aj Giustini; E Demidenko; R Ivkov; S Barry; P Chinn; A Foreman
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-23

7.  Nanoscale thermal phenomena in the vicinity of magnetic nanoparticles in alternating magnetic fields.

Authors:  Andreina Chiu-Lam; Carlos Rinaldi
Journal:  Adv Funct Mater       Date:  2016-03-31       Impact factor: 18.808

8.  Comparison of magnetic nanoparticle and microwave hyperthermia cancer treatment methodology and treatment effect in a rodent breast cancer model.

Authors:  Alicia A Petryk; Andrew J Giustini; Rachel E Gottesman; B Stuart Trembly; P Jack Hoopes
Journal:  Int J Hyperthermia       Date:  2013-12       Impact factor: 3.914

9.  Increased cellular uptake of biocompatible superparamagnetic iron oxide nanoparticles into malignant cells by an external magnetic field.

Authors:  Sara Prijic; Janez Scancar; Rok Romih; Maja Cemazar; Vladimir B Bregar; Andrej Znidarsic; Gregor Sersa
Journal:  J Membr Biol       Date:  2010-07-03       Impact factor: 1.843

10.  Thermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9.

Authors:  Yiqun Du; Dongsheng Zhang; Hui Liu; Rensheng Lai
Journal:  BMC Biotechnol       Date:  2009-10-05       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.